Low-dose methotrexate is ineffective in primary biliary cirrhosis: Long- term results of a placebo-controlled trial

Gastroenterology

Volumn 117, Issue 2, 1999, Pages 400-407

  Hendrickse, M T ^a   Rigney, E ^a   Giaffer, M H ^a   Soomro, I ^a   Triger, D R ^a   Underwood, J C E ^a   Gleeson, D ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; METRONIDAZOLE; PLACEBO;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROSCOPY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0032815689     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1999.0029900400     Document Type: Article

References (26)

1. M.M. Kaplan Primary biliary cirrhosis N Engl J Med 335 1996 1570 1580
2. J. Neuberger Primary biliary cirrhosis Lancet 350 1987 875 879
3. R.E. Poupon K.D. Lindor K. Cauch-Dudek E.R. Dickson R. Poupon E.J. Heathcote Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis Gastroenterology 113 1997 884 889
4. H. Tang J. Neuberger Methotrexate in gastroenterology—dangerous villain or simply misunderstood Aliment Pharmacol Ther 10 1996 851 858
5. M.M. Kaplan T.A. Knox Treatment of primary biliary cirrhosis with low-dose weekly methotrexate Gastroenterology 101 1991 1332 1338
6. A. Sharma S. Provenzale A. Mckusick M.M. Kaplan Interstitial pneumonitis after low-dose methotrexate in primary biliary cirrhosis Gastroenterology 107 1994 266 270
7. M.M. Kaplan R.A. Delellis H.J. Wolfe Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment Ann Intern Med 126 1997 682 688
8. H.P. Buscher Y. Zeitzschmann W. Gerok Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone J Hepatol 18 1993 9 14
9. N.V. Bergasa E.A. Jones D.E. Kleiner L. Rabin Y. Park M.C. Wells J. Hoofnagle Pilot study of low-dose oral methotrexate treatment for primary biliary cirrhosis Am J Gastroenterol 91 1996 295 299
10. H.S. Conjeevaram N.V. Bergasa D.E. Kleiner R. Sallie M. Wells J. Hoofnagle Methotrexate therapy of primary biliary cirrhosis: 2 yr study comparing two dif ferent doses (abstr) Hepatology 22 1995 124A
11. N. Bach S.N. Thung F. Schaffner The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis Arch Pathol Lab Med 122 1998 342 345
12. K.D. Lindor E.R. Dickson R.A. Jorgensen M.L. Anderson R.H. Wiesner G.H. Gores S.M. Lange S.S. Rossi A.F. Hofmann W.P. Baldus The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study Hepatology 22 1995 1158 1162
13. M.M. Kaplan G. Dickstein C. Schmid Methotrexate improves histology in primary biliary cirrhosis (abstr) Hepatology 20 1994 152A
14. A.G. Koch J. Brahm C. Antezana G. Smok M. Cumsille The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone J Hepatol 27 1997 143 149
15. P.J. Scheuer Liver biopsy interpretation 4th ed 1988 Balliere Tindall London
16. P. Invernizzi A. Crosignani P.M. Battezzati Comparison of the clinical features and clinical course of antimitochondrial antibody positive and negative primary biliary cirrhosis Hepatology 25 1997 1090 1095
17. Z.D. Goodman P.R. Mcnally D. Davis K.G. Ishak Autoimmune hepatitis: a variant of primary biliary cirrhosis. Clinico-pathologic and serologic correlations in 200 cases Dig Dis Sci 40 1995 1232 1234
18. E.R. Dickson P.M. Grambusch T.R. Fleming L.D. Fisher A. Langworthy Prognosis in primary biliary cirrhosis: model for decision making Hepatology 10 1989 1 7
19. J. Ludwig E.R. Dickson G.S. Mcdonald Staging of non-suppurative cholangitis (syndrome of primary biliary cirrhosis Virchows Arch A Pathol Anat Histopathol 329 1978 103 112
20. R.G. Knodell K.G. Ishak W.C. Black T.S. Chen R. Craig N. Kaplowitz T.W. Kiernan J. Wollman Formulation and application of a numeri-cal scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
21. P. Armitage G. Berr y Statistical methods in medical research 3rd ed 1994 Cambridge University Cambridge, England
22. E. Christensen Multivariate survival analysis using Cox's regression model Hepatology 6 1987 1346 1356
23. HH Roenigk R Aurbach HI Maibach Weinstein Methotrexate in psoriasis: revised guidelines J AmAcad Dermatol 19 1989 145 156
24. M.E. Weinblatt B.N. Weissman D.E. Holdsworth P.A. Fraser A.L. Maier K.R. Falchuk J.S. Coblyn Long-term prospective study of methotrexate in the treatment of rheumatoid ar thritis: 84 month update Arthritis Rheum 35 1992 129 137
25. C.A. Phillips P.J. Cera T.F. Mangan B.D. Newman Clinical liver disease in patients with rheumatoid ar thritis taking methotrexate J Rheumatol 19 1992 229 233
26. A.M. Walker D. Funch N.A. Dreyer K.G. Tolman J.M. Kremer G.S. Alarcon R.G. Lee M.E. Weinblatt Determinants of serious liver disease in patients receiving low-dose methotrexate for rheumatoid ar thritis Arthritis Rheum 36 1993 329 335